📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Antibody-PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4. (2020)

First Author: Maneiro MA

Attributed to: Site-selective antibody modification by cysteine-to-lysine transfer (CLT) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acschembio.0c00285

PubMed Identifier: 32338867

Publication URI: http://europepmc.org/abstract/MED/32338867

Type: Journal Article/Review

Volume: 15

Parent Publication: ACS chemical biology

Issue: 6

ISSN: 1554-8929